Dual Role of Oxidized LDL on the NF-KappaB Signaling Pathway

References

• Stary, H.C. (1990) "The sequence of cell and matrix changes in atherosclerotic lesions of coronary arteries in the first forty years of life", Fur. Heart J. 11, 3–19.
   Web of Science ®Google Scholar
• Lusis, A.J. (2000) "Atherosclerosis", Nature 407, 233–241.
   PubMed Web of Science ®Google Scholar
• Ross, R. (1993) "The pathogenesis of atherosclerosis: a perspective for the 1990s", Nature 362, 801–809.
   PubMed Web of Science ®Google Scholar
• Witztum, J.L. and Steinberg, D. (1991) "Role of oxidized low density lipoprotein in atherogenesis", J. Clin. Investig. 88, 1785–1792.
   PubMed Web of Science ®Google Scholar
• Napoli, C., de Nigris, E and Palinski, W. (2001) "Multiple role of reactive oxygen species in the arterial wall", J. Cell. Biochem. 82, 674–682.
   PubMed Web of Science ®Google Scholar
• Hajjar, D.P. and Haberland, M.E. (1997) "Lipoprotein trafficking in vascular cells. Molecular Trojan horses and cellular saboteurs", J. Biol. Chem. 272, 22975–22978.
   PubMed Web of Science ®Google Scholar
• Salvayre, R., Auge, N., Benoist, H. and Negre-Salvayre, A. (2002) "Oxidized low-density lipoprotein-induced apopto-sis", Biochim. Biophys. Acta 1585, 213–221.
   PubMed Web of Science ®Google Scholar
• Berliner, J.A., Navab, M., Fogelman, A.M., Frank, J.S., Demer, L.L., Edwards, EA., Watson, A.D. and Lusis, A.J. (1995) "Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics", Circulation 91, 2488–2496.
   PubMed Web of Science ®Google Scholar
• Brand, K., Eisele, T., Kreusel, U., Page, M., Page, S., Haas, M., Gerling, A., Kaltschmidt, C., Neumann, F.J., Mackman, N., Baeurele, P.A., Walli, A.K. and Neumeier, D. (1997) "Dysregulation of monocytic nuclear factor-kappa B by oxidized low-density lipoprotein", Arterioscler. Thromb. Vasc. Biol. 17, 1901–1909.
   PubMed Web of Science ®Google Scholar
• Ghosh, S. and Karin, M. (2002) "Missing pieces in the NF-kappaB puzzle", Cell 109, S81—S96.
   Web of Science ®Google Scholar
• May, M.J. and Ghosh, S. (1998) "Signal transduction through NF-kappa B", Immunol. Today 19, 80–88.
   PubMedGoogle Scholar
• Barnes, P.J. and Karin, M. (1997) "Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases", N. Engl. J. Med. 336, 1066–1071.
   PubMed Web of Science ®Google Scholar
• Valen, G., Yan, Z.Q. and Hansson, G.K. (2001) "Nuclear factor kappa-B and the heart", J. Am. Coll. Cardiol. 38,307–314.
   PubMed Web of Science ®Google Scholar
• Ross, J.S., Stagliano, N.E., Donovan, M.J., Breitbart, R.E. and Ginsburg, G.S. (2001) "Atherosclerosis and cancer: common molecular pathways of disease development and pro-gression", Ann. N.Y. Acad. Sci. 947, 271–292, discussion 292, 273.
   Google Scholar
• Karin, M. (1999) "The beginning of the end: IkappaB kinase (IKK) and NF-kappaB activation", J. Biol. Chem. 274, 27339–27342.
   PubMed Web of Science ®Google Scholar
• Zandi, E. and Karin, M. (1999) "Bridging the gap: composition, regulation, and physiological function of the IkappaB kinase complex", Mol. Cell. Biol. 19, 4547–4551.
   PubMed Web of Science ®Google Scholar
• Karin, M. and Delhase, M. (2000) "The I kappa B kinase (11(K) and NF-kappa B: key elements of proinflammatory signalling", Semin. Immunol. 12, 85–98.
   PubMed Web of Science ®Google Scholar
• Sanz, L., Sanchez, P., Lallena, M.J., Diaz-Meco, M.T. and Moscat, J. (1999) "The interaction of p62 with RIP links the atypical PKCs to NF-kappaB activation", EMBO J. 18, 3044–3053.
   PubMed Web of Science ®Google Scholar
• Ozes, ON., Mayo, L.D., Gustin, J.A., Pfeffer, S.R., Pfeffer, L.M. and Donner, D.B. (1999) "NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase", Nature 401, 82–85.
   PubMed Web of Science ®Google Scholar
• Peters, R.T. and Maniatis, T. (2001) "A new family of 1K1K-related kinases may function as I kappa B kinase kinases", Biochim. Biophys. Acta 1471, M57—M62.
   Web of Science ®Google Scholar
• Bowie, A. and O'Neill, L.A. (2000) "Oxidative stress and nuclear factor-kappaB activation: a reassessment of the evidence in the light of recent discoveries", Biochem. Pharmacol. 59, 13–23.
   PubMed Web of Science ®Google Scholar
• Kamata, H., Manabe, T., Oka, S., Kamata, K. and Hirata, H. (2002) "Hydrogen peroxide activates IkappaB kinases through phosphorylation of serine residues in the activation loops", FEBS Lett. 519, 231–237.
   PubMed Web of Science ®Google Scholar
• Schoonbroodt, S. and Piette, J. (2000) "Oxidative stress interference with the nuclear factor-kappa B activation pathways", Biochem. Pharmacol. 60, 1075–1083.
   PubMed Web of Science ®Google Scholar
• Janssen-Heininger, Y.M., Poynter, M.E. and Baeuerle, P.A. (2000) "Recent advances towards understanding redox mechanisms in the activation of nuclear factor kappaB", Free Radic. Biol. Med. 28, 1317–1327.
   PubMed Web of Science ®Google Scholar
• Brand, K., Page, S., Rogler, G., Bartsch, A., Brandl, R., Knuechel, R., Page, M., Kaltschmidt, C., Baeuerle, EA. and Neumeier, D. (1996) "Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion", J. Clin. Investig. 97, 1715–1722.
   PubMed Web of Science ®Google Scholar
• Hajra, L., Evans, Al., Chen, M., Hyduk, S.J., Collins, T. and Cybulsky, MI. (2000) "The NF-kappa B signal transduction pathway in aortic endothelial cells is primed for activation in regions predisposed to atherosclerotic lesion formation", Proc. Natl Acad. Sci. USA 97, 9052–9057.
   PubMed Web of Science ®Google Scholar
• Ritchie, M.E. (1998) "Nuclear factor-kappaB is selectively and markedly activated in humans with unstable angina pectoris", Circulation 98, 1707–1713.
   PubMed Web of Science ®Google Scholar
• Wilson, S.H., Best, P.J., Edwards, W.D., Holmes, DR., Jr., Carlson, P.J., Celermajer, D.S. and Lerman, A. (2002) "Nuclear factor-kappaB immunoreactivity is present in human coronary plaque and enhanced in patients with unstable angina pectoris", Atherosclerosis 160, 147–153.
   PubMed Web of Science ®Google Scholar
• Liao, F., Berliner, J.A., Mehrabian, M., Navab, M., Demer, L.L., Lusis, A.J. and Fogelman, A.M. (1991) "Minimally modified low density lipoprotein is biologically active in vivo in mice", J. Clin. Investig. 87, 2253–2257.
   PubMed Web of Science ®Google Scholar
• Liao, E, Andalibi, A., deBeer, F.C., Fogelman, A.M. and Lusis, A.J. (1993) "Genetic control of inflammatory gene induction and NF-kappa B-like transcription factor acti-vation in response to an atherogenic diet in mice", J. Clin. Investig. 91, 2572–2579.
   PubMed Web of Science ®Google Scholar
• Wilson, S.H., Caplice, N.M., Simari, R.D., Holmes, D.R., Jr., Carlson, P.J. and Lerman, A. (2000) "Activated nuclear factor-kappaB is present in the coronary vasculature in experimental hypercholesterolemia", Atherosclerosis 148, 23–30.
   PubMed Web of Science ®Google Scholar
• Calara, F., Dimayuga, P., Niemann, A., Thyberg, J., Diczfalusy, U., Witztum, J.L., Palinski, W., Shah, P.K., Cercek, B., Nilsson, J. and Regnstrom, J. (1998) "An animal model to study local oxidation of LDL and its biological effects in the arterial wall", Arterioscler. Thromb. Vasc. Biol. 18, 884–893.
   PubMed Web of Science ®Google Scholar
• Beg, A.A., Sha, W.C., Bronson, R.T., Ghosh, S. and Baltimore, D. (1995) "Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B", Nature 376, 167–170.
   PubMed Web of Science ®Google Scholar
• Natarajan, R., Reddy, M.A., Malik, K.U., Fatima, S. and Khan, B.V. (2001) "Signaling mechanisms of nuclear factor-kappab-mediated activation of inflammatory genes by 13-hydroperoxyoctadecadienoic acid in cultured vascular smooth muscle cells", Arterioscler. Thromb. Vasc. Biol. 21, 1408–1413.
   PubMed Web of Science ®Google Scholar
• Subbanagounder, G., Leitinger, N., Schwenke, D.C., Wong, J.W., Lee, H., Pizza, C., Watson, A.D., Faull, K.F., Fogelman, A.M. and Berliner, J.A. (2000) "Determinants of bioactivity of oxidized phospholipids. Specific oxidized fatty acyl groups at the sn-2 position", Arterioscler. Thromb. Vasc. Biol. 20, 2248–2254.
   PubMed Web of Science ®Google Scholar
• Subbanagounder, G., Watson, A.D. and Berliner, J.A. (2000) "Bioactive products of phospholipid oxidation: isolation, identification, measurement and activities", Free Radic. Biol. Med. 28, 1751–1761.
   PubMed Web of Science ®Google Scholar
• Sugiyama, S., Kugiyama, K., Ogata, N., Doi, H., Ota, Y, Ohgushi, M., Matsumura, T., Oka, H. and Yasue, H. (1998) "Biphasic regulation of transcription factor nuclear factor-kappaB activity in human endothelial cells by lysopho-sphatidylcholine through protein kinase C-mediated pathway", Arterioscler. Thromb. Vasc. Biol. 18, 568–576.
   PubMed Web of Science ®Google Scholar
• Kume, N., Cybulsky, MI. and Gimbrone, M.A., Jr. (1992) "Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells", J. Clin. Investig. 90, 1138–1144.
   PubMed Web of Science ®Google Scholar
• Takahara, N., Kashiwagi, A., Maegawa, H. and Shigeta, Y. (1996) "Lysophosphatidylcholine stimulates the expression and production of MCP-1 by human vascular endothelial cells", Metabolism 45, 559–564.
   PubMed Web of Science ®Google Scholar
• Zhu, Y, Lin, J.H., Liao, H.L., Verna, L. and Stemerman, M.B. (1997) "Activation of ICAM-1 promoter by lysophosphati-dylcholine: possible involvement of protein tyrosine kinases", Biochim. Biophys. Acta 1345, 93–98.
   PubMed Web of Science ®Google Scholar
• Brown, A.J. and Jessup, W. (1999) "Oxysterols and atherosclerosis", Atherosclerosis 142, 1–28.
   PubMed Web of Science ®Google Scholar
• Lizard, G., Gueldry, S., Sordet, 0., Monier, S., Athias, A., Miguet, C., Bessede, G., Lemaire, S., Solary, E. and Gambert, P. (1998) "Glutathione is implied in the control of 7-ketocholesterol-induced apoptosis, which is associated with radical oxygen species production", FASEB J. 12, 1651–1663.
   PubMed Web of Science ®Google Scholar
• Alberti, S., Steffensen, K.R. and Gustafsson, J.A. (2000) "Structural characterisation of the mouse nuclear oxysterol receptor genes LXRalpha and LXRbeta", Gene 243, 93–103.
   PubMed Web of Science ®Google Scholar
• Leonarduzzi, G., Sottero, B. and Poli, G. (2002) "Oxidized products of cholesterol: dietary and metabolic origin, and proatherosclerotic effects (review)", J. Nutr. Biochem. 13, 700 —710.
   PubMed Web of Science ®Google Scholar
• Leonarduzzi, G., Arkan, M.C., Basaga, H., Chiarpotto, E., Sevanian, A. and Poli, G. (2000) "Lipid oxidation products in cell signaling", Free Radic. Biol. Med. 28, 1370–1378.
   PubMed Web of Science ®Google Scholar
• Robbesyn, F., Garcia, V, Auge, N., Vieira, 0., Frisach, ME, Salvayre, R. and Negre-Salvayre, A. (2003) "HDL counter-balance the proinflammatory effect of oxidized LDL by inhibiting intracellular reactive oxygen species rise, protea-some activation, and subsequent NF-kappaB activation in smooth muscle cells", FASEB J. 17, 543–745.
   Web of Science ®Google Scholar
• Parola, M., Robino, G., Marra, F., Pinzani, M., Bellomo, G., Leonarduzzi, G., Chiarugi, P., Camandola, S., Poli, G., Waeg, G., Gentilini, P. and Dianzani, M.U. (1998) "HNE interacts directly with JNK isoforms in human hepatic stellate cells", J. Clin. Investig. 102, 1942–1950.
   PubMed Web of Science ®Google Scholar
• Camandola, S., Scavazza, A., Leonarduzzi, G., Biasi, E, Chiarpotto, E., Azzi, A. and Poli, G. (1997) "Biogenic 4-hydroxy-2-nonenal activates transcription factor AP-1 but not NF-kappa B in cells of the macrophage lineage", Biofactors 6, 173–179.
   PubMed Web of Science ®Google Scholar
• Page, S., Fischer, C., Baumgartner, B., Haas, M., Kreusel, U., Loidl, G., Hayn, M., Ziegler-Heitbrock, H.W., Neumeier, D. and Brand, K. (1999) "4-Hydroxynonenal prevents NF-kappaB activation and tumor necrosis factor expression by inhibiting IkappaB phosphorylation and subsequent proteolysis", J. Biol. Chem. 274, 11611–11618.
   PubMed Web of Science ®Google Scholar
• Maziere, C., Auclair, M., Djavaheri-Mergny, M., Packer, L. and Maziere, J.C. (1996) "Oxidized low density lipoprotein induces activation of the transcription factor NF kappa B in fibroblasts, endothelial and smooth muscle cells", Biochem. Mol. Biol. Int. 39, 1201–1207.
   PubMedGoogle Scholar
• Auge, N., Garcia, V, Maupas-Schwalm, E, Levade, T., Salvayre, R. and Negre-Salvayre, A. (2002) "Oxidized LDL-induced smooth muscle cell proliferation involves the EGF receptor/PI-3 kinase/Akt and the sphingolipid signaling pathways", Arterioscler. Thromb. Vasc. Biol. 22, 1990–1995.
   PubMed Web of Science ®Google Scholar
• Romashkova, J.A. and Makarov, S.S. (1999) "NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling", Nature 401, 86–90.
   PubMed Web of Science ®Google Scholar
• Madrid, L.V., Mayo, M.W., Reuther, J.Y. and Baldwin, A.S., Jr. (2001) "Akt stimulates the transactivation potential of the RelA /p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38", J. Biol. Chem. 276, 18934–18940.
   PubMed Web of Science ®Google Scholar
• Cuvillier, 0., Pirianov, G., Kleuser, B., Vanek, P.C., Coso, 0.A., Gutkind, S. and Spiegel, S. (1996) "Suppression of ceramide-mediated programmed cell death by sphingo-sine-1-phosphate", Nature 381, 800–803.
   Google Scholar
• Xia, P., Wang, L., Gamble, J.R. and Vadas, M.A. (1999) "Activation of sphingosine kinase by tumor necrosis factor-alpha inhibits apoptosis in human endothelial cells", J. Biol. Chem. 274, 34499 —34505.
   Google Scholar
• Xia, P., Gamble, J.R., Rye, K.A., Wang, L., Hii, CS., Cockerill, P., Khew-Goodall, Y., Bert, A.G., Barter, P.J. and Vadas, M.A. (1998) "Tumor necrosis factor-alpha induces adhesion molecule expression through the sphingo-sine kinase pathway", Proc. Natl Acad. Sci. USA 95, 14196–14201.
   PubMed Web of Science ®Google Scholar
• Shatrov, V.A., Lehmann, V. and Chouaib, S. (1997) "Sphingosine-1-phosphate mobilizes intracellular calcium and activates transcription factor NF-kappa B in U937 cells", Biochem. Biophys. Res. Commun. 234, 121–124.
   PubMed Web of Science ®Google Scholar
• Auge, N., Nikolova-Karakashian, M., Carpentier, S., Parthasarathy, S., Negre-Salvayre, A., Salvayre, R., Merrill, A.H., Jr. and Levade, T. (1999) "Role of sphingosine 1-phosphate in the mitogenesis induced by oxidized low density lipoprotein in smooth muscle cells via activation of sphingomyelinase, ceramidase, and sphingosine kinase", J. Biol. Chem. 274, 21533–21538.
   PubMed Web of Science ®Google Scholar
• Cominacini, L., Pasini, A.F., Garbin, U., Davoli, A., Tosetti, ML., Campagnola, M., Rigoni, A., Pastorino, A.M., Lo Cascio, V. and Sawamura, T. (2000) "Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-kappaB through an increased production of intracellular reactive oxygen species", J. Biol. Chem. 275, 12633–12638.
   PubMed Web of Science ®Google Scholar
• Cominacini, L., Rigoni, A., Pasini, A.F., Garbin, U., Davoli, A., Campagnola, M., Pastorino, AM., Lo Cascio, V. and Sawamura, T. (2001) "The binding of oxidized low density lipoprotein (ox-LDL) to ox-LDL receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells through an increased production of superoxide", J. Biol. Chem. 276, 13750–13755.
   PubMed Web of Science ®Google Scholar
• Shimamura, A., Ballif, B.A., Richards, S.A. and Blenis, J. (2000) "Rsk1 mediates a MEK-MAP kinase cell survival signal", Curr. Biol. 10, 127–135.
   PubMed Web of Science ®Google Scholar
• Frodin, M. and Gammeltoft, S. (1999) "Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction", Mol. Cell. Endocrinol. 151, 65–77.
   PubMed Web of Science ®Google Scholar
• Auge, N., Pieraggi, MT., Thiers, J.C., Negre-Salvayre, A. and Salvayre, R. (1995) "Proliferative and cytotoxic effects of mildly oxidized low-density lipoproteins on vascular smooth-muscle cells", Biochem. J. 309, 1015–1020.
   PubMed Web of Science ®Google Scholar
• Ares, M.P., Kallin, B., Eriksson, P. and Nilsson, J. (1995) "Oxidized LDL induces transcription factor activator protein-1 but inhibits activation of nuclear factor-kappa B in human vascular smooth muscle cells", Arterioscler Thromb. Vasc. Biol. 15(10), 1584–1590.
   Google Scholar
• Ohlsson, B.G., Englund, M.C., Karlsson, A.L., Knutsen, E., Erixon, C., Skribeck, H., Liu, Y., Bondjers, G. and Wiklund, 0. (1996) "Oxidized low density lipoprotein inhibits lipopoly-saccharide-induced binding of nuclear factor-kappaB to DNA and the subsequent expression of tumor necrosis factor-alpha and interleukin-1beta in macrophages", J. Clin. Investig. 98, 78–89.
   Google Scholar
• Hourton, D., Stengel, D., Chapman, M.J. and Ninio, E. (2001) "Oxidized low density lipoproteins downregulate LPS-induced platelet-activating factor receptor expression in human monocyte-derived macrophages: implications for LPS-induced nuclear factor-kappaB binding activity", Fur. J. Biochem. 268, 4489–4496.
   Web of Science ®Google Scholar
• Bochkov, V.N. and Leitinger, N. (2003) "Anti-inflammatory properties of lipid oxidation products", J. Mol. Med. 81, 613–626.
   PubMed Web of Science ®Google Scholar
• Caspar-Bauguil, S., Tkaczuk, J., Haure, M.J., Durand, M., Akouffe, J., Thomsen, M., Salvayre, R. and Benoist, H. (1999) "Mildly oxidized low-density lipoproteins decrease early production of interleukin 2 and nuclear factor kappaB binding to DNA in activated T-lymphocytes", Biochem. 1.337,269–274.
   Google Scholar
• Engelmann, B., Zieseniss, S., Brand, K., Page, S., Lentschat, A., Ulmer, A.J. and Gerlach, E. (1999) "Tissue factor expression of human monocytes is suppressed by lysophosphatidylcholine", Arterioscler. Thromb. Vasc. Biol. 19, 47–53.
   PubMed Web of Science ®Google Scholar
• Eligini, S., Brambilla, M., Banfi, C., Camera, M., Sironi, L., Barbieri, S.S., Auwerx, J., Tremoli, E. and Colli, S. (2002) "Oxidized phospholipids inhibit cyclooxygenase-2 in human macrophages via nuclear factor-kappaB /IkappaB-and ERK2-dependent mechanisms", Cardiovasc. Res. 55, 406415.
   Web of Science ®Google Scholar
• Ji, C., Kozak, K.R. and Marnett, L.J. (2001) "IkappaB kinase, a molecular target for inhibition by 4-hydroxy-2-nonenal", J. Biol. Chem. 276, 18223–18228.
   PubMed Web of Science ®Google Scholar
• Vieira, 0., Escargueil-Blanc, I., Jurgens, G., Borner, C., Almeida, L., Salvayre, R. and Negre-Salvayre, A. (2000) "Oxidized LDLs alter the activity of the ubiquitin-protea-some pathway: potential role in oxidized LDL-induced apoptosis", FASEB J. 14, 532–542.
   PubMed Web of Science ®Google Scholar
• Okada, K., Wangpoengtrakul, C., Osawa, T., Toyokuni, S., Tanaka, K. and Uchida, K. (1999) "4-Hydroxy-2-nonenal-mediated impairment of intracellular proteolysis during oxidative stress. Identification of proteasomes as target molecules", J. Biol. Chem. 274, 23787–23793.
   PubMed Web of Science ®Google Scholar
• Uchida, K. (2003) "4-Hydroxy-2-nonenal: a product and mediator of oxidative stress", Prog. Lipid Res. 42, 318–343.
   PubMed Web of Science ®Google Scholar
• Nagy, L., Tontonoz, P, Alvarez, J.G., Chen, H. and Evans, R.M. (1998) "Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma", Cell 93, 229–240.
   PubMed Web of Science ®Google Scholar
• Ricote, M., Li, A.C., Willson, TM., Kelly, C.J. and Glass, C.K. (1998) "The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation", Nature 391, 79–82.
   PubMed Web of Science ®Google Scholar
• Duval, C., Chinetti, G., Trottein, F., Fruchart, J. and Staels, B. (2002) "The role of PPARs in atherosclerosis", Trends Mol. Med. 8, 422–430.
   PubMed Web of Science ®Google Scholar
• Mallat, Z. and Tedgui, A. (2000) "Apoptosis in the vasculature: mechanisms and functional importance", Br. J. Pharmacol. 130, 947–962.
   PubMed Web of Science ®Google Scholar
• Delerive, P., Gervois, P., Fruchart, J.C. and Staels, B. (2000) "Induction of IKBek expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proli-ferator-activated receptor-alpha activators", J. Biol. Chem. 275, 36703–36707.
   PubMed Web of Science ®Google Scholar
• Klucis, E., Crane, D. and Masters, C. (1984) "Sequential alterations in the micro-localization of catalase in mouse liver after treatment with hypolipidemic drugs", Mol. Cell. Biochem. 65, 73–82.
   PubMed Web of Science ®Google Scholar
• Edwards, P.A., Kennedy, M.A. and Mak, P.A. (2002) "LXRs; oxysterol-activated nuclear receptors that regulate genes controlling lipid homeostasis", Vascul. Pharmacol. 38, 249–256.
   PubMed Web of Science ®Google Scholar
• Joseph, S.B., Castrillo, A., Laffitte, B.A., Mangelsdorf, D.J. and Tontonoz, P. (2003) "Reciprocal regulation of inflammation and lipid metabolism by liver X receptors", Nat. Med. 9, 213–219.
   PubMed Web of Science ®Google Scholar
• Castrillo, A., Joseph, S.B., Marathe, C., Mangelsdorf, D.J. and Tontonoz, P. (2003) "Liver X receptor-dependent repression of matrix metalloproteinase-9 expression in macrophages", J. Biol. Chem. 278, 10443–10449.
   PubMed Web of Science ®Google Scholar
• Englund, M.C., Karlsson, A.L., Wiklund, 0., Bondjers, G. and Ohlsson, B.G. (2001) "25-hydroxycholesterol induces lipopolysaccharide-tolerance and decreases a lipopoly-saccharide-induced TNF-alpha secretion in macrophages", Atherosclerosis 158, 61–71.
   PubMed Web of Science ®Google Scholar
• Suske, G. (1999) "The Sp-family of transcription factors", Gene 238, 291–300.
   PubMed Web of Science ®Google Scholar
• Karin, M. and Lin, A. (2002) "NF-kappaB at the crossroads of life and death", Nat. Immunol. 3, 221–227.
   PubMed Web of Science ®Google Scholar
• De Martin, R., Hoeth, M., Hofer-Warbinek, R. and Schmid, J.A. (2000) "The transcription factor NF-kappa B and the regulation of vascular cell function", Arterioscler. Thromb. Vasc. Biol. 20, 83–88.
   PubMed Web of Science ®Google Scholar
• Nishio, E., Kanda, Y, Kuroki, Y. and Watanabe, Y. (2000) "The potentiation of oxLDL induced apoptosis by inhibition of NF-kappaB", Life Sci. 67, 1983–1992.
   PubMed Web of Science ®Google Scholar
• Zen, K., Karsan, A., Stempien-Otero, A., Yee, E., Tupper, J., Li, X., Eunson, T., Kay, M.A., Wilson, C.B., Winn, R.K. and Harlan, J.M. (1999) "NF-kappaB activation is required for human endothelial survival during exposure to tumor necrosis factor-alpha but not to interleukin-1beta or lipopolysaccharide", J. Biol. Chem. 274, 28808–28815.
   PubMed Web of Science ®Google Scholar
• Liu, H., Lo, C.R. and Czaja, M.J. (2002) "NF-kappaB inhibition sensitizes hepatocytes to TNF-induced apoptosis through a sustained activation of INK and c-Jun", Hepatology 35, 772–778.
   PubMed Web of Science ®Google Scholar
• Li, D. and Mehta, J.L. (2000) "Upregulation of endothelial receptor for oxidized LDL (LOX-1) by oxidized LDL and implications in apoptosis of human coronary artery endothelial cells: evidence from use of antisense LOX-1 mRNA and chemical inhibitors", Arterioscler. Thromb. Vasc. Biol. 20, 1116–1122.
   PubMed Web of Science ®Google Scholar
• Aoyama, T., Sawamura, T., Furutani, Y., Matsuoka, R., Yoshida, M.C., Fujiwara, H. and Masaki, T. (1999) "Structure and chromosomal assignment of the human lectin-like oxidized low-density-lipoprotein receptor-1 (LOX-1) gene", Biochem. J. 339, 177–184.
   PubMed Web of Science ®Google Scholar
• Li, D., Saldeen, T., Romeo, F. and Mehta, J.L. (2000) "Oxidized LDL upregulates angiotensin II type 1 receptor expression in cultured human coronary artery endothelial cells: the potential role of transcription factor NF-kappaB", Circulation 102, 1970–1976.
   PubMed Web of Science ®Google Scholar
• Nickenig, G. (2002) "Central role of the AT(1)-receptor in atherosclerosis", J. Hum. Hypertens 16\(Suppl. 3), S26—S33.
   Google Scholar
• Bascands, J.L., Girolami, J.P., Troly, M., Escargueil-Blanc, I., Nazzal, D., Salvayre, R. and Blaes, N. (2001) "Angiotensin II induces phenotype-dependent apoptosis in vascular smooth muscle cells", Hypertension 38, 1294–1299.
   PubMed Web of Science ®Google Scholar
• Hsu, S.C., Gavrilin, M.A., Lee, H.H., Wu, C.C., Han, S.H. and Lai, M.Z. (1999) "NF-kappa B-dependent Fas ligand expression", Fur. J. Immunol. 29, 2948–2956.
   Web of Science ®Google Scholar
• Chan, H., Bartos, D.P. and Owen-Schaub, LB. (1999) "Activation-dependent transcriptional regulation of the human Fas promoter requires NF-kappaB p50—p65 recruit-ment", Mol. Cell. Biol. 19, 2098–2108.
   PubMedGoogle Scholar
• Qin, Z.H., Chen, R.W., Wang, Y., Nakai, M., Chuang, D.M. and Chase, IN. (1999) "Nuclear factor kappaB nuclear translocation upregulates c-Myc and p53 expression during NMDA receptor-mediated apoptosis in rat striatum", J. Neurosci. 19, 4023–4033.
   PubMed Web of Science ®Google Scholar
• Ross, R. (1999) "Atherosclerosis—an inflammatory disease", N. Engl. J. Med. 340, 115–126.
   PubMed Web of Science ®Google Scholar
• Libby, P. (2002) "Inflammation in atherosclerosis", Nature 420, 868–874.
   PubMed Web of Science ®Google Scholar
• Berliner, J.A., Territo, M.C., Sevanian, A., Ramin, S., Kim, J.A., Bamshad, B., Esterson, M. and Fogelman, A.M. (1990) "Minimally modified low density lipoprotein stimulates monocyte endothelial interactions", J. Clin. Investig. 85, 1260–1266.
   PubMed Web of Science ®Google Scholar
• Rajavashisth, TB., Andalibi, A., Territo, M.C., Berliner, J.A., Navab, M., Fogelman, A.M. and Lusis, A.J. (1990) "Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins", Nature 344, 254–257.
   PubMed Web of Science ®Google Scholar
• De Caterina, R., Libby, P., Peng, H.B., Thannickal, V.J., Rajavashisth, T.B., Gimbrone, Jr., M.A., Shin, W.S. and Liao, J.K. (1995) "Nitric oxide decreases cytoldne-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines", J. Clin. Investig. 96, 60–68.
   PubMed Web of Science ®Google Scholar
• Peng, H.B., Spiecker, M. and Liao, J.K. (1998) "Inducible nitric oxide: an autoregulatory feedback inhibitor of vascular inflammation", J. Immunol. 161, 1970–1976.
   PubMed Web of Science ®Google Scholar
• Peng, H.B., Libby, P. and Liao, J.K. (1995) "Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B", J. Biol. Chem. 270, 14214–14219.
   PubMed Web of Science ®Google Scholar
• Matthews, J.R., Botting, C.H., Panico, M., Morris, H.R. and Hay, R.T. (1996) "Inhibition of NF-kappaB DNA binding by nitric oxide", Nucleic Acids Res. 24, 2236–2242.
   PubMed Web of Science ®Google Scholar
• Yang, X., Cai, B., Sciacca, R.R. and Cannon, P.J. (1994) "Inhibition of inducible nitric oxide synthase in macrophages by oxidized low-density lipoproteins", Circ. Res. 74,318–328.
   PubMed Web of Science ®Google Scholar
• Hattori, Y., Hattori, S. and Kasai, K. (2001) "4-Hydroxy-nonenal prevents NO production in vascular smooth muscle cells by inhibiting nuclear factor-kappaB-dependent tran-scriptional activation of inducible NO synthase", Arterioscler. Thromb. Vasc. Biol. 21, 1179–1183.
   PubMed Web of Science ®Google Scholar
• Huang, A., Li, C., Kao, R.L. and Stone, W.L. (1999) "Lipid hydroperoxides inhibit nitric oxide production in RAW264.7 macrophages", Free Radic. Biol. Med. 26, 526–537.
   PubMed Web of Science ®Google Scholar
• Carmeliet, P. and Collen, D. (1998) "Tissue factor", Int. J. Biochem. Cell. Biol. 30, 661–667.
   PubMed Web of Science ®Google Scholar
• Tremoli, E., Camera, M., Toschi, V. and Colli, S. (1999) "Tissue factor in atherosclerosis", Atherosclerosis 144, 273–283.
   PubMed Web of Science ®Google Scholar
• Mackman, N. (1995) "Regulation of the tissue factor gene", FASEB J. 9, 883–889.
   PubMed Web of Science ®Google Scholar
• Brand, K., Banka, CL., Mackman, N., Terkeltaub, R.A., Fan, S.T. and Curtiss, L.K. (1994) "Oxidized LDL enhances lipopolysaccharide-induced tissue factor expression in human adherent monocytes", Art erioscler. Thromb. 14,790–797.
   PubMedGoogle Scholar
• Ardissino, D., Merlini, PA., Arlens, R., Coppola, R., Bramucci, E., Lucreziotti, S., Repetto, A., Fetiveau, R. and Mannucci, P.M. (2000) "Tissue factor in human coronary atherosclerotic plaques", Clin. Chim. Acta 291, 235–240.
   PubMed Web of Science ®Google Scholar
• Lewis, J.C., Bennett-Cain, AI., DeMars, CS., Doellgast, G.J., Grant, K.W., Jones, N.L. and Gupta, M. (1995) "Procoagulant activity after exposure of monocyte-derived macrophages to minimally oxidized low density lipo-protein. Co-localization of tissue factor antigen and nascent fibrin fibers at the cell surface", Am. J. Pathol. 147, 1029–1040.
   Google Scholar
• Drake, TA., Hannani, K., Fei, H.H., Lavi, S. and Berliner, J.A. (1991) "Minimally oxidized low-density lipoprotein induces tissue factor expression in cultured human endothelial cells", Am. J. Pathol. 138, 601–607.
   PubMed Web of Science ®Google Scholar
• Cui, M.Z., Penn, M.S. and Chisolm, G.M. (1999) "Native and oxidized low density lipoprotein induction of tissue factor gene expression in smooth muscle cells is mediated by both Egr-1 and Sp1", J. Biol. Chem. 274, 32795–32802.
   PubMed Web of Science ®Google Scholar
• Bochkov, V.N., Mechtcheriakova, D., Lucerna, M., Huber, J., Malli, R., Graier, W.F., Hofer, E., Binder, B.R. and Leitinger, N. (2002) "Oxidized phospholipids stimulate tissue factor expression in human endothelial cells via activation of ERK/EGR-1 and Ca(+ + )/NFAT", Blood 99, 199–206.
   PubMed Web of Science ®Google Scholar
• Hone, S., Hiraishi, S., Hirata, Y., Kazama, M. and Matsuda, J. (2000) "Oxidized low-density lipoprotein impairs the anti-coagulant function of tissue-factor-pathway inhibitor through oxidative modification by its high association and accelerated degradation in cultured human endothelial cells", Biochem. J. 352, 277–285.
   PubMed Web of Science ®Google Scholar
• Hone, S., Hiraishi, S., Hamuro, T., Kamikubo, Y. and Matsuda, J. (2002) "Oxidized low-density lipoprotein associates strongly with carboxy-terminal domain of tissue factor pathway inhibitor and reduces the catalytic activity of the protein", Thromb. Haemost. 87, 80–85.
   PubMed Web of Science ®Google Scholar